Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 13/12/2019
SIETES contiene 92852 citas

 
 
 1 a 20 de 91 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Fuentes Camps I, Rodríguez A, Agustí A. Non-commercial vs. commercial clinical trials: a retrospective study of the applications submitted to a research ethics committee . Br J Clin Pharmacol 2018;84:junio. [Ref.ID 102808]
2. Cita con resumen
Grosser T, Ricciotti E, Fitzgerald GA. The cardiovascular pharmacology of nonsteroidal anti-inflammatory drugs. Trends Pharmacol Sci 2017;38:733-48. [Ref.ID 101990]
3. Cita con resumen
Pedro-Botet J, Rubiés-Prat J. Statin-associated muscle symptoms: beware of the nocebo effect. Lancet 2017;389:2445-6. [Ref.ID 101655]
4. Cita con resumen
Gotzsche PC, Young AH, Crace J. Does long term use of psychiatric drugs cause more harm than good?. BMJ 2015;350:h2435. [Ref.ID 99101]
5. Cita con resumen
Wartolowska K, Judge A, Hopewell S, Collins GS, Dean BJF, Rombach I, Brindley D, Savulescu J, Beard DJ, Carr AJ. Use of placebo controls in the evaluation of surgery: systematic review. BMJ 2014;348:g3253. [Ref.ID 98009]
7. Cita con resumen
Gotzsche P. Deficiencies in proposed new EU regulation of clinical trials. BMJ 2013;346:21-3. [Ref.ID 94761]
8. Cita con resumen
Chalmers I, Glasziou P, Godlee F. All trials must be registered and the results published. BMJ 2013;346:8. [Ref.ID 94757]
9.Tiene citas relacionadas Cita con resumen
Thornton JG. HRT and cardiovascular events. Press release was misleading. BMJ 2012;345:27. [Ref.ID 94212]
10.Tiene citas relacionadas Cita con resumen
Schierbeck LL, Kober L, Jensen J-EB. HRT and cardiovascular events. Author's reply. BMJ 2012;345:27. [Ref.ID 94211]
11.Tiene citas relacionadas Cita con resumen
McPherson K. HRT and cardiovascular events. Age hypothesis does not stand. BMJ 2012;345:27. [Ref.ID 94210]
12.Tiene citas relacionadas Cita con resumen
Schroll J, Lundh A. HRT and cardiovascular events. Was composite outcome specified in original protocol?. BMJ 2012;345:26-7. [Ref.ID 94209]
13.Tiene citas relacionadas Cita con resumen
Rossouw JE, Manson JE, Kaunitz AM, Stefanick ML. HRT and cardiovascular events. Safety couldn't be investigated. BMJ 2012;345:26. [Ref.ID 94208]
14.Tiene citas relacionadas Cita con resumen
Marjoribanks J, Farquhar C, Roberts H, Lethaby A. HRT and cardiovascular events. Trial does not change results of Cochrane review. BMJ 2012;345:26. [Ref.ID 94207]
15. Cita con resumen
Savovic J, Jones HE, Altman DG, Harris RJ, Jüni P, Pidal J, Als-Nielsen B, Balk EM, Gluud C, Gluud LL, Ioannidis JPA, Schulz KF, Beynon R, Welton NJ, Wood L, Moher D, Deeks JJ, Sterne JAC. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Ann Intern Med 2012;157:429-38. [Ref.ID 93767]
16. Cita con resumen
Hróbjartsson A, Thomsen ASS, Emanuelsson F, Tendal B, Hilden J, Boutron I, Ravaud P, Brorson S. Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors. BMJ 2012;344:20. [Ref.ID 92611]
17.Tiene citas relacionadas Cita con resumen
Papazian L, Forel J-M, Roch A. Neuromuscular blockers and ARDS. The authors reply. N Engl J Med 2010;363:2563-4. [Ref.ID 89821]
18.Tiene citas relacionadas Cita con resumen
Puthucheary Z, Hart N, Montgomery H. Neuromuscular blockers and ARDS. N Engl J Med 2010;363:2563. [Ref.ID 89820]
19.Tiene citas relacionadas Cita con resumen
Gusmao D. Neuromuscular blockers and ARDS. N Engl J Med 2010;363:2562-3. [Ref.ID 89819]
20.Tiene citas relacionadas Cita con resumen
Devlin JW, Garpestad E, Hill NS. Neuromuscular blockers and ARDS. N Engl J Med 2010;363:2562. [Ref.ID 89818]
Seleccionar todas
 
 1 a 20 de 91 siguiente >>